Skip to main content
All lobbying filings

SCHAERR JAFFE LLP

SCHAERR JAFFE LLP filed a Q2 report for CELLPHIRE THERAPEUTICS, INC. on July 20, 2026.

Lobbying for CELLPHIRE THERAPEUTICS, INC. · biotechnology company

All filings by SCHAERR JAFFE LLP · Everything CELLPHIRE THERAPEUTICS, INC. has reported

 Filing · LD-2 quarterly report Q2 report
Reporting period
2nd Quarter 2026
Apr 1 - June 30 · Posted Jul 20, 2026
Money reported
None
Registrations and no-activity reports carry no figure.
Client based in
Maryland

Official filing document

 Government bodies contacted 1

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

 Lobbying activity 1
Health Issues

Blood platelet technology and the Strategic National Stockpile

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem